Sirtex Medical

Industry · 9 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry) Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC)	—	2023-06-19
Completed	SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasm	Phase 4	2023-04-25
Active Not Recruiting	Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresec Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma	N/A	2021-05-28
Terminated	SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Intrahepatic Cholangiocarcinoma	Phase 2 / Phase 3	2017-02-14
Completed	FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal C Colorectal Cancer Metastatic	Phase 3	2013-05-01
Withdrawn	FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colore Colorectal Carcinoma, Liver Metastases	Phase 2 / Phase 3	2008-07-01
Terminated	SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma Carcinoma, Hepatocellular, Hepatoma	N/A	2007-07-18
Completed	FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal C Colorectal Cancer, Colorectal Carcinoma, Liver Metastases	N/A	2006-08-01
Completed	SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Hepatocellular Carcinoma	Phase 2	2006-03-01